Read News By Date

MONMOUTH JUNCTION, NJ, April 21, 2026 — Biotech SupportGroup (BSG), a pioneer in proteomics sample preparation,reports on the use of AlbuSorb™ in a sensing platformfor comprehensive quality assessment of complex culturemedia in cell manufacturing.
ReadMore

MONMOUTH JUNCTION, NJ, March 18, 2026 — Biotech SupportGroup (BSG), a leader in proteomics sample preparation,highlights a recent study utilizing its proprietarylipid removal reagent, Cleanascite™, to investigatemechanisms of immunotherapy resistance in ovarian canceromental metastases.
ReadMore

MONMOUTH JUNCTION, NJ, March 16, 2026 — Biotech SupportGroup (BSG), a pioneer in proteomics sample preparation,reports on the use of AlbuSorb™ PLUS in a groundbreakingstudy published in the European Journal of Pharmacology.
ReadMore

MONMOUTH JUNCTION, NJ, February 17, 2026 — A researchteam from Taipei Medical University, describesHemogloBind™ methods as advantageous in a proteomiccomparison of lung and intestinal tissues from miceexposed to high temperature, low temperature, andhigh-to-low temperature groups.
ReadMore

MONMOUTH JUNCTION, NJ, February 17, 2026 — BiotechSupport Group (BSG) reports on its proprietary lipidremoval reagent, Cleanascite™, in a worm model study ofsignaling pathways that promote death avoidance, andthus, survival of conspecifics.
ReadMore

MONMOUTH JUNCTION, NJ, February 17, 2026 — An articlelet by researchers from The University of Burdwan, Indiautilized HemoVoid™ enrichment in a multi-omic study ofthalassemia. The citation is: Mitra, Nibedita, et al."Multi-omics analysis of red blood cells revealsthalassemia severity beyond globin gene mutations."Blood Advances (2026): bloodadvances-2025016677.
ReadMore

MONMOUTH JUNCTION, NJ, February 6, 2026 — BiotechSupport Group (BSG) reports on its proprietary lipidremoval reagent, Cleanascite™, as a essential method toassess the functional effects of circulating lipidsafter stroke.
ReadMore

MONMOUTH JUNCTION, NJ, January 29, 2026 — BiotechSupport Group (BSG) reports on its proprietary lipidremoval reagent, Cleanascite™, in a mouse model study ofneuronal protein maintenance and the accumulation ofprotein aggregates with ageing.
ReadMore

MONMOUTH JUNCTION, NJ, January 19, 2026 — BiotechSupport Group (BSG) reports on its NRicher™-derivedproduct, AlbuVoid™, for secretome analysis of a humaninduced pluripotent stem cell (hiPSC) -derived productto promote successful reproductive outcomes.
ReadMore

MONMOUTH JUNCTION, NJ, January 5, 2026– A researchpre-print entitled “Ubiquitination and degradation ofCD47 enhances macrophage phagocytosis of hemolyticerythrocytes“, describes HemogloBind™ methods toadvantage in a proteomic comparison of erythrocytes.
ReadMore

MONMOUTH JUNCTION, NJ, November 26, 2025– A posterpresented at the 2025 Human Proteome (HUPO) WorldCongress, highlights the advantage of HemoVoid™enrichment in proteomic study of dried blood cards. Theposter was presented by researchers from the Centre forProteome Research at University of Liverpool andentitled “HAEMOGLOBIN INTERFERENCE IN DRIED BLOOD SPOTPROTEOMICS FOR CHRONIC KIDNEY DISEASE”.
ReadMore

MONMOUTH JUNCTION, NJ, November 25, 2025 — BiotechSupport Group (BSG) exhibited at the 2025 World HumanProteome (HUPO) Congress, November 9-13, 2025 in TorontoCanada..
ReadMore

MONMOUTH JUNCTION, NJ, November 24, 2025 — BiotechSupport Group (BSG) reports on use of its proprietarylipid removal reagent, Cleanascite™, to developimproved, translatable in vitro models for human TumorAssociated Macrophages (TAMs).
ReadMore

MONMOUTH JUNCTION, NJ, November 24, 2025 — BiotechSupport Group (BSG) reports on its proprietary lipidremoval reagent, Cleanascite™, in a nanopore detectionstudy of the anticancer drug, Actinomycin D.
ReadMore

MONMOUTH JUNCTION, NJ, November 20, 2025 — BiotechSupport Group (BSG) reports on its NRicher™-derivedproduct, AlbuVoid™, in a targeted proteomic analysis ofastrocyte-specific APO E4 to E2 switching in a mousemodel of Alzheimer’s disease.
ReadMore

MONMOUTH JUNCTION, NJ, November 18, 2025 — BiotechSupport Group (BSG) reports on its proprietary lipidremoval reagent, Cleanascite™, in a cell response studyof CD8 + T cells in the tumor microenvironment.
ReadMore

MONMOUTH JUNCTION, NJ, October 17, 2025 — BiotechSupport Group (BSG) reports on its proprietary lipidremoval reagent, Cleanascite™, in a rat model study ofchemical exposure and thyroid hormone metabolismdisruption.
ReadMore

MONMOUTH JUNCTION, NJ, October 6, 2025– A posterpresented at the 2025 American Society for MassSpectrometry (ASMS) Conference, highlights the advantageof HemoVoid™ enrichment. The study from researchers atStanford University entitled “Parkinson’s Diseasebiomarker discovery via LC-MS/MS characterization andquantification of alpha synuclein PTMs in erythrocytes”demonstrates an observational advantage of HemoVoid™enrichment compared to alternatives.
ReadMore

MONMOUTH JUNCTION, NJ, October 6, 2025– A researcharticle published in Malaysian Applied Biology,highlights AlbuSorb™ as a simple Albumin Removal methodin a proteomic study of fish sera. The study fromresearchers at Universiti Malaya entitled “Pleurotuspulmonarius Stalk Waste Extract SupplementationModulates Serum Proteins Level in Red Hybrid TilapiaOreochromis sp. upon PAMPs Challenge” demonstrates theefficiency of Albumin removal using AlbuSorb™.
ReadMore

MONMOUTH JUNCTION, NJ, September 25, 2025– A studypublished in the International Journal of ChronicObstructive Pulmonary Disease entitled “ProteomeProfiling of Red Blood Cells from Patients with COPDLinks Proteasome Activation with Abnormal CellMorphology and Function” provides an in-depth Red BloodCell (RBC) proteome profile of chronic obstructivepulmonary disease (COPD). To achieve this, theinvestigators utilized HemoVoid™, BSG’s hemoglobinremoval product, to perform a comparative proteomicanalysis on RBC lysates.
ReadMore

MONMOUTH JUNCTION, NJ, September 3, 2025 — BiotechSupport Group (BSG) reports on its proprietary lipidremoval reagent, Cleanascite™, in a mouse model study ofthe neuronal proteome and its turnover with aging, itspropensity to aggregate, and its interaction withmicroglia.
ReadMore

MONMOUTH JUNCTION, NJ, August 25, 2025– A pre-printstudy published by researchers at the University of Utahentitled “Lean breast adipocytes secrete an oxylipinthat suppresses breast cancer via ferroptosis” hasuncovered a linoleic acid-derived oxylipin, 9S-HODE,secreted by lean breast adipocytes, which suppressesbreast cancer growth through the induction offerroptosis. The study, investigating the mechanisticbasis of obesity-associated breast cancer progression,leveraged Cleanascite™, BSG’s proprietary lipidclearance reagent, to dissect lipid-mediated signalingwithin the adipocyte secretome.
ReadMore

MONMOUTH JUNCTION, NJ, July 25, 2025 — In this study,researchers have uncovered critical mechanisms drivingimmune suppression in hepatocellular carcinoma (HCC),highlighting the role of oxidized LDL (oxLDL) inpromoting protumor macrophage polarization. Central tothe study's methodology was the use of Cleanascite™, alipid-binding reagent from Biotech Support Group, whichenabled the researchers to efficiently isolate and studylipid-influences from tumor interstitial fluid (TIF).
ReadMore

MONMOUTH JUNCTION, NJ, July 22, 2025 -- Biotech SupportGroup (BSG) announces a pivotal role for its proprietarylipid removal reagent, Cleanascite™, in a newlypublished study in the Journal of Experimental Medicineexploring metabolic reprogramming in cancer-associatedfibroblasts (CAFs) and its impact on tumor progression.
ReadMore

MONMOUTH JUNCTION, NJ, June 11, 2025 -- Biotech SupportGroup reports on a journal article describing thesimplicity and efficiency of HemogloBind™, to removeHemoglobin prior to mass spectrometry-coupled cellularthermal shift assay (MS-CETSA) of red blood cells.
ReadMore

MONMOUTH JUNCTION, NJ, June 10, 2025 -- Biotech SupportGroup reports on a journal article describing thesimplicity and efficiency of HemogloBind™, to removeHemoglobin prior to LC-MS/MS proteomic analysis ofintestinal tissues.
ReadMore

MONMOUTH JUNCTION, NJ, May 13, 2025 -- Biotech SupportGroup reports on an article, describing the simplicityand efficiency of their lipid depletion product to studylipid influence in cell culture models of natural killer(NK) cells, from patients with High-grade serous ovariancancer (HGSOC).
ReadMore

MONMOUTH JUNCTION, NJ, April 30, 2025 -- Biotech SupportGroup reports on an article, describing the simplicityand efficiency of their lipid depletion product to studylipid influence in models of melanoma metastasis in cellculture and mice.
ReadMore

MONMOUTH JUNCTION, NJ, April 25, 2025 -- Biotech SupportGroup will have an exhibit booth #811, at the 2025 TheAmerican Society for Mass Spectrometry Annual Meeting,June 1 - 5, 2025 at the Baltimore Convention Center. Themeeting will have 6,500 scientists and 3,000 talks andposters.
ReadMore

MONMOUTH JUNCTION, NJ, April 21, 2025 -- Biotech SupportGroup reports on a journal article describing thesimplicity and efficiency of HemogloBind™, to removeHemoglobin prior to LC-MS/MS proteomic analysis.
ReadMore

MONMOUTH JUNCTION, NJ, April 4, 2025 -- Biotech SupportGroup will have an exhibit booth #428 at the 2025 TheAmerican Society for Biochemistry and Molecular BiologyAnnual Meeting, April 12-15, in Chicago IL. The ASBMBannual meeting is attended by over 2,500 researchers inacademia and industry, educators, trainees and studentsfrom across the globe.
ReadMore

MONMOUTH JUNCTION, NJ, April 2, 2025 -- Biotech SupportGroup reports on an article, describing the simplicityand efficiency of their lipid clearance product to studyuniversal lipid factors associated with endoplasmicreticulum stress and metabolic diseases.
ReadMore

MONMOUTH JUNCTION, NJ, March 31, 2025 -- Biotech SupportGroup announces receipt of a NEW JERSEY COMMISSION ONSCIENCE, INNOVATION AND TECHNOLOGY Phase II CatalystResearch Award of $40,000. The Research Award entitled“Evaluating the NRicher™ Bead Platform for TargetedLC-MS Quantification” will be conducted at The RutgersBiological Mass Spectrometry Facility. This awardfollows from the Catalyst Phase I Award demonstratingsimple workflows that generate low abundance enrichmentof sub-proteomes suitable for quantitative plasmaproteomics.
ReadMore

MONMOUTH JUNCTION, NJ, March 6, 2025 -- Biotech SupportGroup reports on a research article describing thesimplicity and efficiency of their HemoVoid™ technologyfor enriching erythrocyte low abundance proteins, inorder to assess heat stress in dairy buffaloes.
ReadMore

MONMOUTH JUNCTION, NJ, March 6, 2025 -- Biotech SupportGroup reports on a research article describing thesimplicity and efficiency of their HemoVoid™ technologyfor enriching erythrocyte low abundance proteins, inorder to assess dysregulated pathways associated withThalassemia severity.
ReadMore

MONMOUTH JUNCTION, NJ, March 6, 2025 -- Biotech SupportGroup reports on an article, describing the simplicityand efficiency of their lipid clearance product to studylipid accumulation models of disease in mice.
ReadMore

MONMOUTH JUNCTION, NJ, January 30, 2025 -- BiotechSupport Group reports on a journal article usingAlbuSorb™ PLUS in a functional proteomic study of howanti-protease and complement activity increase withCOVID-19 severity.
ReadMore

MONMOUTH JUNCTION, NJ, January 6, 2025 -- BiotechSupport Group reports on a journal article usingAlbuSorb™ PLUS in a proteomic study of how systemicinflammation negatively impacts health and production indairy cows.
ReadMore

MONMOUTH JUNCTION, NJ, December 30, 2024 -- BiotechSupport Group reports on an article, describing thesimplicity and efficiency of their lipid clearancesample preparation from integrated stress models ofdisease in mice.
ReadMore

MONMOUTH JUNCTION, NJ, December 16, 2024 -- BiotechSupport Group reports on an article, describing thesimplicity and efficiency of their lipid clearancesample preparation in a study of HDL-associated VitaminD Binding Protein (DBP) correlates with disease severityin psoriasis and cardiovascular disease.
ReadMore

MONMOUTH JUNCTION, NJ, December 9, 2024 -- BiotechSupport Group reports on an article, describing thesimplicity and efficiency of their lipid clearancesample preparation from plasma for mass spectrometrymeasurement of intact insulin and C-peptide.
ReadMore

MONMOUTH JUNCTION, NJ, November 5, 2024 -- BiotechSupport Group reports on a recent journal article usingAlbuVoid™ for investigating the protein secretome fromdifferentiated ovarian support cells (OSCs).
ReadMore

MONMOUTH JUNCTION, NJ, November 4, 2024 -- BiotechSupport Group reports on a journal article describingthe simplicity and efficiency of HemogloBind™, to removeHemoglobin interference prior to an invitro-cross-linking protocol, to determine the relativelevels of disordered and higher-ordered multimeric formsof cytosolic α-synuclein in blood.
ReadMore

MONMOUTH JUNCTION, NJ, November 4, 2024 -- BiotechSupport Group reports on an article, describing thesimplicity and efficiency of their lipid clearancesample preparation from cultured primary humanneutrophils isolated from the blood of healthy donorswith cancer supernatants from various human cancer celllines.
ReadMore

MONMOUTH JUNCTION, NJ, November 4, 2024 -- BiotechSupport Group reports on an article, describing thesimplicity and efficiency of their lipid clearancesample preparation from cultured primary humanneutrophils isolated from the blood of healthy donorswith cancer supernatants from various human cancer celllines.
ReadMore

MONMOUTH JUNCTION, NJ, October 1, 2024 -- BiotechSupport Group reports on a journal article describingthe simplicity and efficiency of HemogloBind™, to removeHemoglobin interference prior to virus capture usinghydrogel particles coupled with chemical affinity baits.
ReadMore

MONMOUTH JUNCTION, NJ, September 9, 2024 -- BiotechSupport Group reports on an article, describing thesimplicity and efficiency of their lipid clearancesample preparation from omental conditioned medium(OCM), to in a study of protumoral M2-like macrophagesin ovarian cancer.
ReadMore

MONMOUTH JUNCTION, NJ, August 26, 2024 -- BiotechSupport Group reports on a journal article describingthe simplicity and efficiency of using Cleanascite™ toeliminate interferences from lipids and lipoproteinsthat nonspecifically interact with a nanopore channel.
ReadMore

MONMOUTH JUNCTION, NJ, August 26, 2024 -- BiotechSupport Group reports on a journal article describingthe simplicity and efficiency of using Cleanascite™ toprepare and contrast lipid-free cell culture media forevaluating Bacterial vaginosis (BV).
ReadMore

MONMOUTH JUNCTION, NJ, June 27, 2024 -- Biotech SupportGroup reports on a research article, describing thesimplicity and efficiency of their differentialproteomic enrichment technology to observe and annotatemultiprotein complexes in Toxoplasma gondii, a majorfood borne pathogen.
ReadMore

MONMOUTH JUNCTION, NJ, June 19, 2024 -- Biotech SupportGroup reports on an article, describing the simplicityand efficiency of their lipid clearance samplepreparation technology to determine the role of lipidsin a study about the impact of chronic phthalateexposure on liver cancer development.
ReadMore

MONMOUTH JUNCTION, NJ, May 7, 2024 -- Biotech SupportGroup (BSG) reports that two of their joint authorshipjournal articles were cited in the supporting discussionfrom the research article:
ReadMore

MONMOUTH JUNCTION, NJ, April 5, 2024 -- Biotech SupportGroup exhibited at two recent conferences: the US HumanProteome Organization (US HUPO) 2024 Conference, March9-13, 2024 in Portland, OR, and MSACL 2024 14th AnnualConference organized by the Association for MassSpectrometry & Advances in the Clinical Lab (MSACL)March 17 - 22, 2024 in Monterey, CA. These conferenceshighlight the most recent advancements in Proteomics andMass Spectrometry technology and applications, each withattendance of 400-500 scientists.
ReadMore

MONMOUTH JUNCTION, NJ, March 28, 2024 -- Biotech SupportGroup reports on a journal article describing thesimplicity and efficiency of HemogloBind™, to removeHemoglobin interference prior to a point-of-care (POC)electrochemical biosensor for sepsis biomarkers.
ReadMore

MONMOUTH JUNCTION, NJ, March 28, 2024 -- Biotech SupportGroup reports on an article, describing the simplicityand efficiency of their lipid clearance samplepreparation technology to determine the role oflipid-associated factors in the brain’s primary residentimmune cells – the microglia, and the secretion of toxiclong-chain lipids that impair neuron and oligodendrocytehomeostasis.
ReadMore

MONMOUTH JUNCTION, NJ, February 19, 2024 -- BiotechSupport Group reports on a journal article describingthe simplicity and efficiency of combining two of BSG’sproducts in series, HemogloBind™ and HemoVoid™, topurify Hemoglobin for peptide mass fingerprinting (PMF)analysis.
ReadMore

MONMOUTH JUNCTION, NJ, December 13, 2023 -- BiotechSupport Group reports on a journal article describingthe simplicity and efficiency of HemogloBind™, to removeHemoglobin interference prior to LC-MS proteomicanalysis of red blood cells.
ReadMore

MONMOUTH JUNCTION, NJ, December 13, 2023 -- BiotechSupport Group reports on a journal article describingthe simplicity and efficiency of HemogloBind™, to removeHemoglobin interferences prior to analysis.
ReadMore

MONMOUTH JUNCTION, NJ, December 12, 2023 -- BiotechSupport Group reports on an article, describing thesimplicity and efficiency of their lipid clearancesample preparation technology to determine the role oflipid-associated factors in adipocyte signaling andfibroblast to myofibroblast conversion .
ReadMore

MONMOUTH JUNCTION, NJ, November 14, 2023 -- BiotechSupport Group reports on a journal research articledescribing the simplicity and efficiency of their lipidclarification technology for purifying a monoclonalantibody from ascites fluid.
ReadMore

MONMOUTH JUNCTION, NJ, October 17, 2023 -- BiotechSupport Group reports on two journal articles describingthe simplicity and efficiency of HemogloBind™, to removeHemoglobin interferences prior to analysis.
ReadMore

MONMOUTH JUNCTION, NJ, October 17, 2023 -- BiotechSupport Group reports on a recent research articledescribing the simplicity and efficiency of their lipidbinding technology for purifying and analyzing Lysyloxidase (LOX) from bovine aorta.
ReadMore

MONMOUTH JUNCTION, NJ, October 16, 2023 -- BiotechSupport Group reports on a research article describingthe simplicity and efficiency of their HemoVoid™technology for enriching erythrocyte low abundanceproteins, in order to assess post-translationalmodifications of α-synuclein through a biologicalnanopore.
ReadMore

MONMOUTH JUNCTION, NJ, September 14, 2023 -- BiotechSupport Group reports on a journal article describingthe simplicity and efficiency of HemogloBind™, to removeHemoglobin interference, in a study investigating sicklecell disease.
ReadMore

MONMOUTH JUNCTION, NJ, August 21, 2023 -- BiotechSupport Group reports on a recent journal article usingAlbuSorb™ to determine the how Albumin buffers theinflammatory impact of glycoconjugates derived fromintestinal Firmicute cell walls.
ReadMore

MONMOUTH JUNCTION, NJ, July 17, 2023 -- Biotech SupportGroup reports on a journal article describing thesimplicity and efficiency of NuGel™ HemogloBind™, toremove Hemoglobin interference, in a LC-MS amino acidanalysis of mouse tumor interstitial fluid.
ReadMore

MONMOUTH JUNCTION, NJ, July 17, 2023 -- Biotech SupportGroup reports on a recent research article describingthe simplicity and efficiency of their lipid bindingtechnology for purifying coupled nanoparticles.
ReadMore

MONMOUTH JUNCTION, NJ, June 14, 2023 -- Biotech SupportGroup reports on an article, describing the simplicityand efficiency of their lipid clearance samplepreparation technology to help determine the role offatty acids in the suppression of T cell function in thebone marrow microenvironment.
ReadMore

MONMOUTH JUNCTION, NJ, May 11, 2023 -- Biotech SupportGroup reports on an article, describing the simplicityand efficiency of their lipid binding technology todetermine the influence of lipid LTB4R2 ligands withinpathways associated with Hepatocellular carcinoma.
ReadMore

MONMOUTH JUNCTION, NJ, May 4, 2023 -- Biotech SupportGroup will exhibit at the annual American Society forMass Spectrometry (ASMS) Conference, June 4-8, 2023 inHouston, TX. The conference highlights the most recentadvancements in Mass Spectrometry technology andapplications, with attendance of 6,000 – 7,000scientists and over 2,700 poster presentations and 384talks.
ReadMore

MONMOUTH JUNCTION, NJ, March 24, 2023 -- Biotech SupportGroup reports on a journal article describing thesimplicity and efficiency of HemogloBind™, to removeHemoglobin interference, in a study investigatingerythrocytotoxicity from silica nanoparticles (SiNPs).
ReadMore

MONMOUTH JUNCTION, NJ, March 22, 2023 -- Biotech SupportGroup reports on a recent research article describingthe simplicity and efficiency of their lipid clearancesample preparation technology for proteomic screening ofnovel biomarkers in bile fluid.
ReadMore

MONMOUTH JUNCTION, NJ, February 16, 2023 -- BiotechSupport Group reports on a journal article describingthe simplicity and efficiency of NuGel™ HemogloBind™, toremove Hemoglobin interference, in a LC-MS metabolomicanalysis of plasma in a dietary study of adults withepilepsy.
ReadMore

MONMOUTH JUNCTION, NJ, February 9, 2023 -- BiotechSupport Group reports on a journal article describingthe simplicity and efficiency of HemogloBind™, to purifyHemoglobin, in a nano LC−MALDI MS/MS measurement ofsingle amino acid mutations in Hb variants.
ReadMore

MONMOUTH JUNCTION, NJ, January 31, 2023 -- BiotechSupport Group reports on an article, describing thesimplicity and efficiency of their lipid bindingtechnology to determine the influence long-chain fattyacids on CD8+ T cell metabolism and function in MultipleMyeloma.
ReadMore

MONMOUTH JUNCTION, NJ, January 27, 2023 -- BiotechSupport Group reports on an article, describing thesimplicity and efficiency of their lipid bindingtechnology to determine the influence of probioticmembrane vesicles on antimicrobial activity.
ReadMore

MONMOUTH JUNCTION, NJ, January 12, 2023 -- BiotechSupport Group reports on a research article describingthe simplicity and efficiency of their lipid clearancesample preparation technology in a two step purificationmethod for High-density lipoproteins (HDLs) in order tomeasure transport amounts of small RNAs .
ReadMore

MONMOUTH JUNCTION, NJ, January 9, 2023 -- BiotechSupport Group (BSG) reports on joint publication withauthors from research collaborators at Leiden UniversityMedical Center, describing the developmental andanalytical aspects of Tier 2 LC-MRM-MS proteinquantification methods for liquid biopsies, with aspecial focus on BSG’s Stroma Liquid Biopsy™ proteinpanel.
ReadMore

MONMOUTH JUNCTION, NJ, January 9, 2023 -- BiotechSupport Group reports on a journal article describingthe simplicity and efficiency of HemogloBind™,Hemoglobin depletion technology for removing analyticalinterferences, in the measurement ofAcetylcholinesterase and Butyryl cholinesteraseactivity.
ReadMore

MONMOUTH JUNCTION, NJ, January 9, 2023 -- BiotechSupport Group reports on an article, describing thesimplicity and efficiency of their lipid clearancetechnology for depletion of lipids from omentalconditioned medium (OCM) to determine their influence ontumor-associated macrophages (TAMs)
ReadMore

MONMOUTH JUNCTION, NJ, December 19, 2022 -- BiotechSupport Group reports on an article, describing theirlipid clearance sample preparation technology to helpdetermine the role of fatty acid oxidation andmitochondrial metabolism in a cell response study ofmurine cell culture models of susceptibility toinfection.
ReadMore

MONMOUTH JUNCTION, NJ, November 29, 2022 -- BiotechSupport Group reports on a research article describingthe simplicity and efficiency of their hemoglobindepletion technology for enriching erythrocyte proteins,in order to assess proteomic differences associated withCOPD by LC-MS analysis.
ReadMore

MONMOUTH JUNCTION, NJ, October 11, 2022 -- BiotechSupport Group reports on a Nature article showing theuse of AlbuSorb™ for immunoblotting of intestinalorganoid supernatants.
ReadMore

MONMOUTH JUNCTION, NJ, September 13, 2022 -- BiotechSupport Group reports on a new research articledescribing the simplicity and efficiency of their virusenrichment technology for Sindbis virus (SINV) expressedin cell culture.
ReadMore

MONMOUTH JUNCTION, NJ, September 9, 2022 -- BiotechSupport Group reports on a research article describingthe simplicity and efficiency of their hemoglobindepletion technology for enriching blood cell proteinsin rhesus monkeys, in order to assess proteomicdifferences associated with aging by LC-MS analysis.
ReadMore

MONMOUTH JUNCTION, NJ, August 29, 2022 -- BiotechSupport Group reports on an article, describing thesimplicity and efficiency of their lipid clearancesample preparation technology to help determine the roleof lipogenesis in a cell response study of pulmonaryarterial vascular smooth muscle cells.
ReadMore

MONMOUTH JUNCTION, NJ, February 22, 2017 -- BiotechSupport Group reports on a new research report whichhighlights the simplicity and efficiency of theirproteomic sample preparation technology as an initialenrichment step to the Array Bridge (St. Louis, MO)Protein Elution Plate (PEP).
ReadMore

MONMOUTH JUNCTION, NJ -- Biotech Support Group reportson a recent research article which supports the utilityof their lipid ...
ReadMore

MONMOUTH JUNCTION, NJ, Jan. 6, 2014 -- Biotech Support Group reports on a recent researcharticle which describes the simplicity and ...
ReadMore